ZIOPHARM Oncology Cash from Operations Quarterly:
-18.24M for March 31, 2013ZIOPHARM Oncology Historical Cash from Operations Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -18.24M |
| Dec. 31, 2012 | -21.50M |
| Sept. 30, 2012 | -14.71M |
| June 30, 2012 | -16.76M |
| March 31, 2012 | -25.86M |
| Dec. 31, 2011 | -13.75M |
| Sept. 30, 2011 | -11.10M |
| June 30, 2011 | -5.822M |
| March 31, 2011 | -8.167M |
| Dec. 31, 2010 | -5.783M |
| Sept. 30, 2010 | -5.807M |
| June 30, 2010 | -4.315M |
| March 31, 2010 | -3.789M |
| Dec. 31, 2009 | -3.393M |
| Sept. 30, 2009 | -2.066M |
| June 30, 2009 | -2.225M |
| March 31, 2009 | -4.61M |
| Dec. 31, 2008 | -3.804M |
| Sept. 30, 2008 | -5.891M |
| June 30, 2008 | -6.352M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Cash From Operations
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.
Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More
ZIOP Cash from Operations Quarterly Benchmarks
| Companies | |
|---|---|
| Threshold Pharmaceuticals | 33.48M |
| United Therapeutics Corporation | 97.70M |
| Omeros Corporation | -12.78M |
ZIOP Cash from Operations Quarterly Rankings
| Overall |
47th percentile 4221 of 8002 |
| Sector |
23rd percentile 497 of 650 in Healthcare |
| Industry |
27th percentile 171 of 237 in Biotechnology |
ZIOP Cash from Operations Quarterly Range, Past 5 Years
| Minimum | -25.86M | Mar 2012 |
| Maximum | -2.066M | Sep 2009 |
| Average | -9.197M |
